Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Theranostics|April 22, 2024
The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancerMinsu Park, Eunsun Jung, Jung Min Park, et al.
Bioorganic & Medicinal Chemistry|March 5, 2019
Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agentsHo Shin Kim, Van-Hai Hoang, Mannkyu Hong, et al.
Nature Communications|March 9, 2024
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trialLiang Huang, Da Pang, Hongjian Yang, et al.
American Journal of Hematology|November 20, 2004
Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): case reportIn Keun Choi, Byung-Soo Kim, Kyung-A Lee, et al.
Expert Opinion on Biological Therapy|April 26, 2024
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance studyMin Ho Park, Jae Hong Seo, Jung Ho Park, et al.
Cancer Research and Treatment|August 5, 2016
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study ResultsYeon Hee Park, Tae Yong Kim, Young-Hyuck Im, et al.
Cancer Research and Treatment|September 14, 2016
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast CancerIn Hae Park, Joo Hyuk Sohn, Sung Bae Kim, et al.
Oncology Reports|July 14, 2005
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factorSeock-Ah Im, Sung-Bae Kim, Moon Hee Lee, et al.
Cytokine|March 26, 2021
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)Ju Won Kim, Soohyeon Lee, Hye Sook Kim, et al.
Cancer Medicine|November 14, 2022
Perception and safety analysis of COVID-19 vaccination in cancer patients: A multicenter, real-world studyKyoungmin Lee, In Hae Park, Sang Cheul Oh, et al.
Pageof 17